Clinical significance of MEFV mutations in ankylosing spondylitis

Joint Bone Spine

Volumn 76, Issue 3, 2009, Pages 260-264

  Durmus, Dilek ^a   Alayli, Gamze ^a   Cengiz, Kivanc ^a   Yigit, Serbulent ^a   Canturk, Ferhan ^a   Bagci, Hasan ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Disease activity; Gene mutation; MEFV

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEFV GENE; PAIN; RATING SCALE; SCHOBER TEST; VISUAL ANALOG SCALE;

ADULT; CYTOSKELETAL PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS; HLA-B27 ANTIGEN; HUMANS; MUTATION; ODDS RATIO; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 67349174682     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.09.011     Document Type: Article

References (33)

1. Braun J., and Sieper J. Ankylosing spondylitis. Lancet 369 (2007) 1379-1390
2. Zochling J., Braun J., and van der Heijde D. Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 20 (2006) 521-537
3. Brown M.A. Human leucocyte antigen-B27 and ankylosing spondylitis. Intern Med J 37 (2007) 739-740
4. Wordsworth P. Genes in the spondyloarthtopathies. Rheum Dis Clin North Am 4 (1998) 845-862
5. Brown M.A. Non-major-histocompatibility-complex genetics of ankylosing spondylitis. Best Pract Res Clin Rheumatol 20 (2006) 611-621
6. Sohar E., Gafni J., Pras M., et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43 (1967) 227-253
7. French FMF Consortium. A candidate gene for familial mediteranean fever. Nat Genet 17 (1997) 25-31
8. Lachmann H.J., Sengül B., Yavuzşen T.U., et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45 (2006) 746-750
9. Turkish FMF Study Group. Familial Mediterranean fever in Turkey. Medicine 84 (2005) 1-11
10. Yigit S., Bagci H., Ozkaya O., et al. MEFV mutations in patients with familian Mediterianean fever in the Black Sea region of Turkey. J Rheumatol 35 (2008) 106-113
11. Korkmaz C., Ozdogan H., Kasapcopur O., et al. Acute phase response in Familial Mediterranean fever. Ann Rheum Dis 61 (2002) 79-81
12. Tunca M., Kirkali G., Soyturk M., et al. Acute phase response and evaluation of familial Mediterranean fever. Lancet 353 (1999) 1415
13. Ozen S., Bakkaloglu A., Yi{dotless}lmaz E., et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation?. J Rheumatol 30 (2003) 2014-2018
14. Rabinovich E., Shinar Y., Leiba M., et al. Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis. Scand J Rheumatol 36 (2007) 48-52
15. Rabinovich E., Livneh A., Langevitz P., et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 64 (2005) 1009-1014
16. Shinar Y., Livneh A., Villa Y., et al. Common mutations in the Mediterranean fever gene associated with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun 4 (2003) 197-203
17. Giaglis S., Mimidis K., Papadopoulos V., et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect. Dig Dis Sci 51 (2006) 687-692
18. Duman I., Balaban B., Tugcu I., et al. Familial Mediterranean fever unusually coexisted in an ankylosing spondylitis patients. MEFV mutation has any role?. Rheumatol Int 27 (2007) 689-690
19. Kaushik P., el-Sobkie N.I., Shehab D., et al. Familial Mediterranean fever with HLA B-27 positive ankylosing spondylitis in a young Armenian man. Clin Exp Rheumatol 17 (1999) 387-388
20. Langevitz P., Livneh A., Zemer D., et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 27 (1997) 67-72
21. Van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for the modification of the New York criteria. Arthritis Rheum 27 (1984) 361-368
22. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
23. Oberkanins C., Weinhausel A., Krieqshauser G., et al. Genetic testing for familial Mediterranean fever in Austria by means of reverse-hybridization teststrips. Clin Chem 49 (2003) 1948-1950
24. Pile K.D., Laurent M.R., Salmond C.E., et al. Clinical assessment of ankylosing spondylitis. Br J Rheumatol 30 (1991) 29-34
25. Garrett S., Jenkinson T., Kennedy L.G., et al. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21 (1994) 2286-2291
26. Ozer H.T., Sarpel T., Gulek B., et al. The Turkish version of the bath ankylosing spondylitis functional index: reliability and validity. Clin Rheumatol 24 (2005) 123-128
27. Fidder H., Chowers Y., Ackerman Z., et al. The familial Mediterranean fever gene as a modifier of Crohn's disease. Am J Gastroenterol 100 (2005) 338-343
28. Amor B., Santos R.S., Nahal R., et al. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 21 (1994) 1883-1887
29. Hamersma J., Cardon L.R., Bradbury L., et al. Is disease severity in ankylosing spondylitis genetically determined?. Arthritis Rheum 44 (2001) 1396-1400
30. Khan M., Kushner I., and Braun W. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 20 (1977) 909-912
31. Linssen A. B27 positive disease versus B27 negative disease. Scand J Rheumatol 87 Suppl (1990) 111-118 discussion 118-9
32. Freeston J., Barkham N., Hensor E., et al. Ankylosing spondylitis, HLA-B27 positivity and need for biologic therapies. Joint Bone Spine 74 (2007) 140-143
33. Brown M.A., Brophy S., Bradbury L., et al. Identification of major loci contolling clinical manifestations of ankylosing spondylitis. Arthritis Rheum 48 (2003) 2234-2239